-
1
-
-
0026086423
-
Cardiovascular function in hemodialysis patients
-
London GM, Marchais SJ, Guérin AP, Fabiani F, Metivier F. Cardiovascular function in hemodialysis patients. Adv. Nephrol. 1991; 20: 249-73.
-
(1991)
Adv. Nephrol.
, vol.20
, pp. 249-273
-
-
London, G.M.1
Marchais, S.J.2
Guérin, A.P.3
Fabiani, F.4
Metivier, F.5
-
2
-
-
0028313403
-
Risk factors for the development of left ventricular hypertrophy in a prospective cohort of dialysis patients
-
Harnett JD, Knet GM, Barre PE, Taylor R, Parfrey PS. Risk factors for the development of left ventricular hypertrophy in a prospective cohort of dialysis patients. J. Am. Soc. Nephrol. 1994; 1: 1486-90.
-
(1994)
J. Am. Soc. Nephrol.
, vol.1
, pp. 1486-1490
-
-
Harnett, J.D.1
Knet, G.M.2
Barre, P.E.3
Taylor, R.4
Parfrey, P.S.5
-
3
-
-
0029900359
-
Outcome and risk factors for left ventricular disorders in chronic uremia
-
Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol. Dial. Transplant. 1996; 11: 1277-85.
-
(1996)
Nephrol. Dial. Transplant.
, vol.11
, pp. 1277-1285
-
-
Parfrey, P.S.1
Foley, R.N.2
Harnett, J.D.3
Kent, G.M.4
Murray, D.C.5
Barre, P.E.6
-
4
-
-
0028953102
-
Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
-
Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int. 1995; 47: 884-90.
-
(1995)
Kidney Int.
, vol.47
, pp. 884-890
-
-
Harnett, J.D.1
Foley, R.N.2
Kent, G.M.3
Barre, P.E.4
Murray, D.5
Parfrey, P.S.6
-
5
-
-
0018965458
-
Cardiac hypertrophy: Useful adaptation or pathological process?
-
Grossman W. Cardiac hypertrophy: Useful adaptation or pathological process? Am. J. Med. 1989; 69: 576-84.
-
(1989)
Am. J. Med.
, vol.69
, pp. 576-584
-
-
Grossman, W.1
-
6
-
-
0034751209
-
A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients
-
Stack AG, Bloembergen WE. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am. J. Kidney Dis. 2001; 38: 992-1000.
-
(2001)
Am. J. Kidney Dis.
, vol.38
, pp. 992-1000
-
-
Stack, A.G.1
Bloembergen, W.E.2
-
7
-
-
0035132108
-
Cause and management of heart failure in patients with chronic renal disease
-
Al-Ahmad A, Sarnak MJ, Salem DN, Konstam MA. Cause and management of heart failure in patients with chronic renal disease. Semin. Nephrol. 2001; 21: 3-12.
-
(2001)
Semin. Nephrol.
, vol.21
, pp. 3-12
-
-
Al-Ahmad, A.1
Sarnak, M.J.2
Salem, D.N.3
Konstam, M.A.4
-
8
-
-
0025729993
-
Brain natriutetic peptide as a novel cardiac hormone in humans
-
Mukoyama M, Nakao K, Hosoda K et al. Brain natriutetic peptide as a novel cardiac hormone in humans. J. Clin. Invest. 1991; 87: 1402-12.
-
(1991)
J. Clin. Invest.
, vol.87
, pp. 1402-1412
-
-
Mukoyama, M.1
Nakao, K.2
Hosoda, K.3
-
9
-
-
0028359997
-
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patietns with heart failure
-
Yasue H, Yoshimura M, Sumida H et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patietns with heart failure. Circulation 1994; 90: 195-203.
-
(1994)
Circulation
, vol.90
, pp. 195-203
-
-
Yasue, H.1
Yoshimura, M.2
Sumida, H.3
-
10
-
-
0029834931
-
Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
-
Yamamoto K, Burnett Jr JC, Jougasaki M et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988-94.
-
(1996)
Hypertension
, vol.28
, pp. 988-994
-
-
Yamamoto, K.1
Burnett J.C., Jr.2
Jougasaki, M.3
-
11
-
-
0031693057
-
Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis
-
Nitta K, Kawashima A, Yumura W et al. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis. Am. J. Nephrol 1998; 18: 411-15.
-
(1998)
Am. J. Nephrol
, vol.18
, pp. 411-415
-
-
Nitta, K.1
Kawashima, A.2
Yumura, W.3
-
12
-
-
0035069834
-
Diagnostic potential of cardiac natriuretic peptide in dialysis patients
-
Mallamaci F, Zoccali C, Tripepi G et al. Diagnostic potential of cardiac natriuretic peptide in dialysis patients. Kidney Int. 2001; 59: 1559-66.
-
(2001)
Kidney Int.
, vol.59
, pp. 1559-1566
-
-
Mallamaci, F.1
Zoccali, C.2
Tripepi, G.3
-
13
-
-
0018231715
-
The Committee on M-Mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements
-
Sahn DJ, DeMaria A, Kisso J, Weyman A. The Committee on M-Mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
-
(1978)
Circulation
, vol.58
, pp. 1072-1083
-
-
Sahn, D.J.1
DeMaria, A.2
Kisso, J.3
Weyman, A.4
-
14
-
-
0027258966
-
Methods for detection of left ventricular hypertrophy: Application to hypertensive heart disease
-
Devereux RB, Koren MJ, deSimone G, Okin PM, Kligfield P. Methods for detection of left ventricular hypertrophy: Application to hypertensive heart disease. Eur. Heart J. 1993; 14 (Suppl. D): 8-15.
-
(1993)
Eur. Heart J.
, vol.14
, Issue.SUPPL. D
, pp. 8-15
-
-
Devereux, R.B.1
Koren, M.J.2
DeSimone, G.3
Okin, P.M.4
Kligfield, P.5
-
15
-
-
0025159069
-
Left ventricular hypertrophy in men with normal blood pressure: Relation to exaggerated blood pressure response to exercise
-
Gottdiener JS, Brown J, Zoltick J, Fletcher RD. Left ventricular hypertrophy in men with normal blood pressure: Relation to exaggerated blood pressure response to exercise. Ann. Intern. Med. 1990; 112: 161-6.
-
(1990)
Ann. Intern. Med.
, vol.112
, pp. 161-166
-
-
Gottdiener, J.S.1
Brown, J.2
Zoltick, J.3
Fletcher, R.D.4
-
16
-
-
0030741179
-
Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone
-
Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J. Am. Coll. Cardiol. 1997; 30: 8-18.
-
(1997)
J. Am. Coll. Cardiol.
, vol.30
, pp. 8-18
-
-
Nishimura, R.A.1
Tajik, A.J.2
-
17
-
-
0034765282
-
Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling
-
Cataliotti A, Malatino LS, Jougasaki M et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin. Proc. 2001; 76: 1111-19.
-
(2001)
Mayo Clin. Proc.
, vol.76
, pp. 1111-1119
-
-
Cataliotti, A.1
Malatino, L.S.2
Jougasaki, M.3
-
18
-
-
0031772642
-
Measurement and significance of circulating natriuretic peptides in cardiovascular disease
-
Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin. Sci. 1998; 95: 519-29.
-
(1998)
Clin. Sci.
, vol.95
, pp. 519-529
-
-
Sagnella, G.A.1
-
19
-
-
0026781270
-
Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure
-
Buckley MG, Sethi D, Markandu ND et al. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin. Sci. 1992; 83: 437-44.
-
(1992)
Clin. Sci.
, vol.83
, pp. 437-444
-
-
Buckley, M.G.1
Sethi, D.2
Markandu, N.D.3
-
20
-
-
0027298699
-
Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes
-
Yamazaki T, Tobe K, Hoh E et al. Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes. J. Biol. Chem. 1993; 268: 12 069-76.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 12069-12076
-
-
Yamazaki, T.1
Tobe, K.2
Hoh, E.3
-
21
-
-
0029090205
-
Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes
-
Yamazaki T, Komuro I, Kudoh S et al. Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes. J. Clin. Invest. 1995; 96: 438-46.
-
(1995)
J. Clin. Invest.
, vol.96
, pp. 438-446
-
-
Yamazaki, T.1
Komuro, I.2
Kudoh, S.3
-
22
-
-
0027722248
-
Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vivo
-
Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vivo. Cell 1993; 75: 977-84.
-
(1993)
Cell
, vol.75
, pp. 977-984
-
-
Sadoshima, J.1
Xu, Y.2
Slayter, H.S.3
Izumo, S.4
-
23
-
-
0027182438
-
Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts
-
Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Circ. Res. 1993; 73: 413-23.
-
(1993)
Circ. Res.
, vol.73
, pp. 413-423
-
-
Sadoshima, J.1
Izumo, S.2
-
24
-
-
0028206850
-
Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro
-
Kojima M, Shiojima I, Yamazaki T et al. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation 1994; 89: 2204-11.
-
(1994)
Circulation
, vol.89
, pp. 2204-2211
-
-
Kojima, M.1
Shiojima, I.2
Yamazaki, T.3
-
25
-
-
0027257160
-
Endothelin-1 is an autocine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes
-
Ito H, Hirata Y, Adachi S et al. Endothelin-1 is an autocine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J. Clin. Invest. 1993; 92: 398-403.
-
(1993)
J. Clin. Invest.
, vol.92
, pp. 398-403
-
-
Ito, H.1
Hirata, Y.2
Adachi, S.3
-
26
-
-
0028182649
-
Endothelin ETA antagonist blocks cardiac hypertrophy provoked by hemodynamic overload
-
Ito H, Hiroe M, Hirata Y et al. Endothelin ETA antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation 1994; 89: 2198-203.
-
(1994)
Circulation
, vol.89
, pp. 2198-2203
-
-
Ito, H.1
Hiroe, M.2
Hirata, Y.3
-
27
-
-
0027302878
-
Association of diabetes mellitus with coronary atherosclerosis and myocardial lesions
-
Burchfiel CM, Reed DM, Marcus EB, Strong JP, Hayashi T. Association of diabetes mellitus with coronary atherosclerosis and myocardial lesions. Am. J. Epidemiol. 1993; 137: 1328-40.
-
(1993)
Am. J. Epidemiol.
, vol.137
, pp. 1328-1340
-
-
Burchfiel, C.M.1
Reed, D.M.2
Marcus, E.B.3
Strong, J.P.4
Hayashi, T.5
-
28
-
-
0026506429
-
Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease
-
Perez JE, McGill JB, Santiago JV et al. Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J. Am. Coll. Cardiol. 1992; 19: 1154-62.
-
(1992)
J. Am. Coll. Cardiol.
, vol.19
, pp. 1154-1162
-
-
Perez, J.E.1
McGill, J.B.2
Santiago, J.V.3
-
29
-
-
0028946936
-
Increased echodensity of myocardial wall in the diabetic heart: An ultrasound tissue characterization study
-
DiBello V, Talarico L, Picano E et al. Increased echodensity of myocardial wall in the diabetic heart: An ultrasound tissue characterization study. J. Am. Coll. Cardiol. 1995; 25: 1408-15.
-
(1995)
J. Am. Coll. Cardiol.
, vol.25
, pp. 1408-1415
-
-
DiBello, V.1
Talarico, L.2
Picano, E.3
-
30
-
-
0033974161
-
Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure
-
Hayashi T, Suzuki A, Shoji T et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am. J. Kidney Dis. 2000; 35: 250-6.
-
(2000)
Am. J. Kidney Dis.
, vol.35
, pp. 250-256
-
-
Hayashi, T.1
Suzuki, A.2
Shoji, T.3
-
31
-
-
0025357286
-
Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin
-
Silberberg J, Racine N, Barre P, Sniderman AD. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can. J. Cardiol. 1990; 6: 1-4.
-
(1990)
Can. J. Cardiol.
, vol.6
, pp. 1-4
-
-
Silberberg, J.1
Racine, N.2
Barre, P.3
Sniderman, A.D.4
-
32
-
-
0029972850
-
Progesterone binding to mineralocorticoid receptors: In vitro and in vivo studies
-
Myles K, Funder JW. Progesterone binding to mineralocorticoid receptors: In vitro and in vivo studies. Am. J. Physiol. 1996; 270: E601-7.
-
(1996)
Am. J. Physiol.
, vol.270
-
-
Myles, K.1
Funder, J.W.2
-
33
-
-
0023221667
-
Cloning of human mineralocorticoid receptor complementary DNA. Structural and functinal kinship with the glucocorticoid receptors
-
Arriza JL, Weinberger C, Cerelli G et al. Cloning of human mineralocorticoid receptor complementary DNA. Structural and functinal kinship with the glucocorticoid receptors. Science 1987; 237: 268-75.
-
(1987)
Science
, vol.237
, pp. 268-275
-
-
Arriza, J.L.1
Weinberger, C.2
Cerelli, G.3
-
34
-
-
0028785677
-
Determination of cardiac fibrosis in experimental hypermineralocorticoid states
-
Young M, Head J, Funder JW. Determination of cardiac fibrosis in experimental hypermineralocorticoid states. Am. J. Physiol. 1995; 269: E657-62.
-
(1995)
Am. J. Physiol.
, vol.269
-
-
Young, M.1
Head, J.2
Funder, J.W.3
-
35
-
-
0028290539
-
Mineralocorticoids, hypertension, and cardiac fibrosis
-
Young M, Fullerton M, Dilley R, Funder JW. Mineralocorticoids, hypertension, and cardiac fibrosis. J. Clin. Invest. 1994; 93: 2578-83.
-
(1994)
J. Clin. Invest.
, vol.93
, pp. 2578-2583
-
-
Young, M.1
Fullerton, M.2
Dilley, R.3
Funder, J.W.4
-
36
-
-
0032885976
-
Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis
-
Sato A, Funder JW, Saruta T. Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis. Am. J. Hypertens. 1999; 12: 867-73.
-
(1999)
Am. J. Hypertens.
, vol.12
, pp. 867-873
-
-
Sato, A.1
Funder, J.W.2
Saruta, T.3
|